Protocol Summary
- Protocol No.
- PSCI-18-143
- Prinicipal Investigator
- Rovito, Marc
- Phase
- Phase II
- Age Group
- Adult
- Scope
- National
- Secondary Protocol No.
- EA5162
- Title
- Phase II Study of Osimertinib in Advanced NSCLC Patients with Exon 20 Mutations in EGFR
- Applicable Disease Sites
- Other
- Status
- Open
- Participating Institutions
- St. Joseph Cancer Center